Mark Laughlin

Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide

Janet M. Harouse, Shama Bhat, Steven L. Spitalnik et al. · Science · 1991 · 519 citations

Immunology, Antiviral Drug, Immunotherapy +18

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

Rachel Courtney, David Wexler, Elaine Radwanski et al. · British Journal of Clinical Pharmacology · 2003 · 324 citations · Full text

Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults

Rachel Courtney, Sudhakar M. Pai, Mark Laughlin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 299 citations · Full text

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

Gordon Wilcock, Sandra E. Black, Suzanne Hendrix et al. · The Lancet Neurology · 2008 · 292 citations

Neurodegenerative Diseases, Alzheimer's Disease, Aging +11

CD4-independent infection of human neural cells by human immunodeficiency virus type 1

Janet M. Harouse, C Kunsch, Heather T. Hartle et al. · Journal of Virology · 1989 · 290 citations · Full text

Immunology, Cd4 Protein, Immunotherapy +16